# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Gaboxadol | 3 | Ki | = | 0.16 | uM | ALA2317990 | 6.80 | nM | |||
2. | Gaboxadol | 3 | EC50 | = | 14 | uM | ALA2317989 | 4.85 | nM | Homo sapiens | ||
3. | Gaboxadol | 3 | pEC50 | = | 4.85 | ALA2317989 | 4.85 | nM | Homo sapiens | |||
4. | Gaboxadol | 3 | AC50 | 39.811 | uM | ALA3562119 | inactive | nM | ||||
5. | Gaboxadol | 3 | pIC50 | < | 4.7 | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | |||
6. | Gaboxadol | 3 | IC50 | > | 0 | M | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
7. | Gaboxadol | 3 | inhibition | = | -2.77 | % | ALA4808150 | % | Homo sapiens | |||
8. | Gaboxadol | 3 | inhibition | = | 2.64 | % | ALA4808149 | % | Homo sapiens | |||
9. | Gaboxadol | 3 | Activity | 0 | ALA3807274 | Active | ||||||
10. | Gaboxadol | 3 | INH | = | -42 | % | ALA4221095 | % | Homo sapiens | |||
11. | Gaboxadol | 3 | Ac50 | 39.811 | uM | ALA3561990 | inactive | uM | ||||
12. | Gaboxadol | 3 | Potency | 10 | uM | ALA1614211 | inactive | nM | Homo sapiens | |||
13. | Gaboxadol | 3 | AC50 | 0 | ALA1741323 | inactive | Homo sapiens | |||||
14. | Gaboxadol | 3 | AC50 | 0 | ALA1741321 | inactive | Homo sapiens | |||||
15. | Gaboxadol | 3 | AC50 | 0 | ALA1741324 | inactive | Homo sapiens | |||||
16. | Gaboxadol | 3 | AC50 | = | 25.119 | uM | ALA1741323 | 4.60 | inconclusive | nM | Homo sapiens | |
17. | Gaboxadol | 3 | AC50 | 0 | ALA1741321 | inactive | Homo sapiens | |||||
18. | Gaboxadol | 3 | AC50 | 0 | ALA1741322 | inactive | Homo sapiens | |||||
19. | Gaboxadol | 3 | AC50 | 0 | ALA1741323 | inactive | Homo sapiens | |||||
20. | Gaboxadol | 3 | AC50 | 0 | ALA1741324 | inactive | Homo sapiens |